GAMMA Investing’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82K Sell
212
-22
-9% -$155 ﹤0.01% 3748
2026
Q1
$1.51K Sell
234
-25
-10% -$193 ﹤0.01% 3744
2025
Q4
$2.12K Buy
259
+16
+7% +$145 ﹤0.01% 3583
2025
Q3
$2.15K Sell
243
-1,221
-83% -$7.72K ﹤0.01% 3436
2025
Q2
$7.66K Buy
1,464
+1,030
+237% +$5.24K ﹤0.01% 2938
2025
Q1
$2.35K Buy
434
+373
+611% +$1.76K ﹤0.01% 3368
2024
Q4
$279 Buy
+61
New +$312 ﹤0.01% 3666

Other funds holding AVAH

GAMMA Investing's AVAH Position: Q2 2026 in Review

GAMMA Investing reduced its Aveanna Healthcare (AVAH) stake by 9.4% in Q2 2026, selling an estimated $155 and leaving 212 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #3748.

GAMMA Investing first reported a position in AVAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.66K in Q2 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • GAMMA Investing held 212 shares of Aveanna Healthcare worth $1.82K as of Q2 2026.
  • GAMMA Investing sold 22 Aveanna Healthcare shares in Q2 2026, an estimated $155.
  • Aveanna Healthcare made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3748 holding.
  • GAMMA Investing first reported a position in Aveanna Healthcare in Q4 2024 and has held it in 7 quarters since.
  • GAMMA Investing's Aveanna Healthcare position peaked at $7.66K in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.